Edgewood Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-2,500
| Closed | -$70K | – | 81 |
|
|
2023
Q4 | $70K | Hold |
2,500
| – | – | ﹤0.01% | 79 |
|
|
2023
Q3 | $119K | Hold |
2,500
| – | – | ﹤0.01% | 77 |
|
|
2023
Q2 | $240K | Sell |
2,500
-2,500
| -50% | -$240K | ﹤0.01% | 77 |
|
|
2023
Q1 | $567K | Hold |
5,000
| – | – | ﹤0.01% | 67 |
|
|
2022
Q4 | $560K | Hold |
5,000
| – | – | ﹤0.01% | 64 |
|
|
2022
Q3 | $642K | Buy |
+5,000
| New | +$642K | ﹤0.01% | 57 |
|
|
2022
Q2 | – | Sell |
-3,500
| Closed | -$498K | – | 83 |
|
|
2022
Q1 | $498K | Hold |
3,500
| – | – | ﹤0.01% | 69 |
|
|
2021
Q4 | $583K | Buy |
3,500
+500
| +17% | +$83.3K | ﹤0.01% | 66 |
|
|
2021
Q3 | $418K | Buy |
3,000
+1,000
| +50% | +$139K | ﹤0.01% | 72 |
|
|
2021
Q2 | $954K | Buy |
2,000
+750
| +60% | +$358K | ﹤0.01% | 53 |
|
|
2021
Q1 | $515K | Buy |
+1,250
| New | +$515K | ﹤0.01% | 69 |
|